首页> 外文学位 >RANKL, osteoprotegerin, and the risk of low trauma hip fracture in postmenopausal women.
【24h】

RANKL, osteoprotegerin, and the risk of low trauma hip fracture in postmenopausal women.

机译:RANKL,骨保护素和绝经后妇女发生低创伤性髋部骨折的风险。

获取原文
获取原文并翻译 | 示例

摘要

Identifying risk factors of osteoporotic hip fracture is important in our aging population given the physical and economic burdens incurred. The objective of this study was to assess prospectively the association of two bone turnover regulators, receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) with the risk of osteoporotic hip fracture, using the resources of the New York University Women's Health Study (NYUWHS). The endpoint of the study was low-trauma hip fracture, which was shown in a preliminary study to be accurately assessed by self-report. Prior to the start of the nested case-control study, the temporal reliability of OPG and RANKL was also examined, and it was shown that a single measurement in an individual reflects reasonably well the long-term average level within this individual (intraclass correlation coefficients (ICCs) for RANKL and OPG were 0.80 and 0.75, respectively). Out of 14,274 women in the NYUWHS cohort, 116 low-trauma hip fracture cases were identified among participants who were postmenopausal at baseline. Incidence density sampling was used to select two controls for each case (total = 232 controls), matching the case on age at, and date of, blood donation. Using in-house sandwich Enzyme-Linked Immunosorbent Assays (ELISAs), baseline RANKL and OPG in serum were measured and compared between cases and controls. For RANKL, whereas no association was observed overall, there was evidence of effect modification by age at blood donation. RANKL levels were higher in cases than in controls among women ≤60, but lower among women >60 years of age. The odds ratio (OR) for hip fracture was 1.31(95% CI: 1.01, 1.71) for women age 60 or below, and 0.85 (95% CI: 0.68, 1.08) for women over the age of 60. OPG increased with age in both cases and controls (P=0.10 and P=0.004, respectively), but the association between OPG levels and hip-fracture risk was not significant in any age group. Overall, the study suggests that RANKL is associated with the risk of osteoporotic hip fracture but that this association varies according to age, whereas OPG is not associated with risk. These findings require replication in larger studies.
机译:考虑到所造成的身体和经济负担,确定骨质疏松性髋部骨折的危险因素在我们的老龄化人口中很重要。这项研究的目的是使用纽约大学妇女科学基金会的资源,前瞻性地评估两个骨转换调节剂,核因子-κB受体激活剂(RANKL)和骨保护素(OPG)与骨质疏松性髋部骨折的风险之间的关系。健康研究(NYUWHS)。该研究的终点是低创伤性髋部骨折,在一项初步研究中表明,该骨折可以通过自我报告进行准确评估。在开始嵌套病例对照研究之前,还对OPG和RANKL的时间可靠性进行了检查,结果表明,个体中的一次测量合理地反映了该个体中的长期平均水平(类内相关系数RANKL和OPG的(ICC)分别为0.80和0.75)。在NYUWHS队列的14,274名妇女中,基线绝经后的参与者中确定了116例低创伤性髋部骨折病例。发病密度采样用于为每个病例选择两个对照(总计= 232个对照),以匹配献血年龄和献血日期的情况。使用内部三明治夹心酶联免疫吸附测定(ELISA),测量血清中的基线RANKL和OPG并在病例与对照之间进行比较。对于RANKL,虽然总体上未观察到关联,但有证据显示献血时年龄会改变效果。 ≤60岁的女性中,RANKL的水平高于对照组,但> 60岁的女性中,较低。 60岁或以下女性髋部骨折的优势比(OR)为1.31(95%CI:1.01,1.71),60岁以上女性为0.85(95%CI:0.68,1.08)。OPG随着年龄的增长而增加在两种情况下和对照中(分别为P = 0.10和P = 0.004),但OPG水平与髋部骨折风险之间的关联在任何年龄组中均不显着。总体而言,该研究表明,RANKL与骨质疏松性髋部骨折的风险有关,但是这种关联随年龄而变化,而OPG与风险无关。这些发现需要在更大的研究中重复。

著录项

  • 作者

    Meserve, Hiroko Watanabe.;

  • 作者单位

    New York University.;

  • 授予单位 New York University.;
  • 学科 Health Sciences Medicine and Surgery.;Health Sciences Epidemiology.;Health Sciences Public Health.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 186 p.
  • 总页数 186
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 11:37:19

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号